Evidence map›Paper›PMID 18687792›Full record

ArticleThe Journal of molecular diagnostics : JMD2008

Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling.

Anna E Szafranska, Timothy S Davison, Jaclyn Shingara, Martina Doleshal, Judith A Riggenbach, Carl D Morrison, Scott Jewell, Emmanuel Labourier

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Canine urothelial carcinoma: a pilot study of microRNA detection in formalin-fixed, paraffin-embedded tissue samples and in normal urine.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. AreCancers · 2019
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. MicroRNA as Biomarkers and Diagnostics.Journal of cellular physiology · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anna E SzafranskaAsuragen, Inc., 2150 Woodward Street, Suite 100, Austin, TX 78744, USA.
Timothy S Davison
Jaclyn Shingara
Martina Doleshal
Judith A Riggenbach
Carl D Morrison
Scott Jewell
Emmanuel Labourier
Asuragen (United States) · USThe Ohio State University · USRoswell Park Comprehensive Cancer Center · US

Funding

miRNA Profiling in Fixed Cancer SamplesR44CA118785 · NCI · ASURAGEN, INC. · PI SCHWARZBACH, ANNA · 2006 to 2009
$1.7M
NCI NIH HHS 1R44CA118785NCI NIH HHS R44 CA118785
6 · The paper itself

Abstract

Formalin-fixed, paraffin-embedded tissues are an invaluable tool for biomarker discovery and validation. As these archived specimens are not always compatible with modern genomic techniques such as gene expression arrays, we assessed the use of microRNA (miRNA) as an alternative means for the reliable molecular characterization of formalin-fixed, paraffin-embedded tissues. Expression profiling using two different microarray platforms and multiple mouse and human formalin-fixed, paraffin-embedded tissue types resulted in the correlation ratios of miRNA expression levels between frozen and fixed tissue pairs ranging from 0.82 to 0.99, depending on the cellular heterogeneity of the tissue type. The same miRNAs were identified as differentially expressed between tissues using both fixed and frozen specimens. While formalin fixation time had only marginal effects on microarray performance, extended storage times for tissue blocks (up to 11 years) resulted in a gradual loss of detection of miRNAs expressed at low levels. Method reproducibility and accuracy were also evaluated in two different tissues stored for different lengths of time. The technical variation between full process replicates, including independent RNA isolation methods, was approximately 5%, and the correlation of expression levels between microarray and real-time quantitative reverse transcriptase polymerase chain reaction was 0.98. Together, these data demonstrate that miRNA expression profiling is an accurate and robust method for the molecular analysis of archived clinical specimens, potentially extending the use of miRNAs as new diagnostic, prognostic, and treatment response biomarkers.

Indexed as

FixativesFormaldehydeAnimalsBrainCryopreservationGene Expression ProfilingHumansIntestine, SmallKidneyLiverMiceMicroRNAsParaffin EmbeddingReproducibility of ResultsSpleenStomachFixativesFormaldehydeMicroRNAs

Identifiers

PMID18687792
PMCPMC2518736
OpenAlexW1965989317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.